Integrated Wealth Concepts’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.31M | Buy |
23,728
+7,002
| +42% | +$379K | 0.01% | 963 |
|
|
2025
Q4 | $820K | Sell |
16,726
-2,419
| -13% | -$113K | 0.01% | 861 |
|
|
2025
Q3 | $826K | Sell |
19,145
-1,820
| -9% | -$71.1K | 0.01% | 1093 |
|
|
2025
Q2 | $805K | Sell |
20,965
-1,119
| -5% | -$42.8K | 0.01% | 1036 |
|
|
2025
Q1 | $856K | Buy |
22,084
+4,451
| +25% | +$163K | 0.01% | 896 |
|
|
2024
Q4 | $596K | Buy |
17,633
+627
| +4% | +$22.6K | 0.01% | 1047 |
|
|
2024
Q3 | $695K | Sell |
17,006
-346
| -2% | -$14.2K | 0.01% | 947 |
|
|
2024
Q2 | $668K | Buy |
17,352
+84
| +0.5% | +$3.53K | 0.01% | 929 |
|
|
2024
Q1 | $740K | Sell |
17,268
-166
| -1% | -$6.85K | 0.01% | 885 |
|
|
2023
Q4 | $646K | Sell |
17,434
-2,208
| -11% | -$79.3K | 0.01% | 893 |
|
|
2023
Q3 | $712K | Sell |
19,642
-157
| -0.8% | -$5.57K | 0.01% | 830 |
|
|
2023
Q2 | $706K | Sell |
19,799
-2,471
| -11% | -$88.6K | 0.01% | 824 |
|
|
2023
Q1 | $792K | Buy |
22,270
+3,519
| +19% | +$123K | 0.02% | 700 |
|
|
2022
Q4 | $659K | Sell |
18,751
-3,795
| -17% | -$126K | 0.02% | 575 |
|
|
2022
Q3 | $664K | Sell |
22,546
-2,149
| -9% | -$81.4K | 0.02% | 519 |
|
|
2022
Q2 | $1.34M | Sell |
24,695
-541
| -2% | -$29.9K | 0.04% | 368 |
|
|
2022
Q1 | $1.37M | Buy |
25,236
+588
| +2% | +$31.9K | 0.04% | 325 |
|
|
2021
Q4 | $1.36M | Buy |
24,648
+4,492
| +22% | +$234K | 0.04% | 338 |
|
|
2021
Q3 | $963K | Buy |
20,156
+8,124
| +68% | +$408K | 0.03% | 392 |
|
|
2021
Q2 | $599K | Sell |
12,032
-1,480
| -11% | -$71.1K | 0.02% | 492 |
|
|
2021
Q1 | $603K | Sell |
13,512
-2,011
| -13% | -$91.3K | 0.02% | 430 |
|
|
2020
Q4 | $714K | Sell |
15,523
-17,419
| -53% | -$800K | 0.03% | 324 |
|
|
2020
Q3 | $1.55M | Buy |
32,942
+8,235
| +33% | +$413K | 0.1% | 159 |
|
|
2020
Q2 | $1.26M | Buy |
24,707
+2,388
| +11% | +$123K | 0.09% | 140 |
|
|
2020
Q1 | $1.06M | Buy |
22,319
+1,799
| +9% | +$96K | 0.1% | 130 |
|
|
2019
Q4 | $1.21M | Buy |
20,520
+11,686
| +132% | +$650K | 0.1% | 129 |
|
|
2019
Q3 | $471K | Buy |
8,834
+4,327
| +96% | +$223K | 0.05% | 218 |
|
|
2019
Q2 | $225K | Sell |
4,507
-762
| -14% | -$38.2K | 0.03% | 340 |
|
|
2019
Q1 | $275K | Buy |
+5,269
| New | +$263K | 0.05% | 255 |
|
|
2018
Q3 | – | Sell |
-4,202
| Closed | -$211K | – | 255 |
|
|
2018
Q2 | $211K | Sell |
4,202
-28
| -0.7% | -$1.41K | 0.07% | 205 |
|
|
2018
Q1 | $205K | Sell |
4,230
-1,015
| -19% | -$47.3K | 0.08% | 189 |
|
|
2017
Q4 | $245K | Buy |
+5,245
| New | +$242K | 0.1% | 157 |
|
Other funds holding GSK
JEST
Integrated Wealth Concepts's GSK Position: Q1 2026 in Review
Integrated Wealth Concepts increased its GSK (GSK) stake by 42% in Q1 2026, buying an estimated $379K and bringing the position to 23,728 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #963.
Integrated Wealth Concepts first reported a position in GSK in Q4 2017 and has held it in 32 quarters since. The position peaked at $1.55M in Q3 2020. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Integrated Wealth Concepts held 23,728 shares of GSK worth $1.31M as of Q1 2026.
- Integrated Wealth Concepts bought 7,002 GSK shares in Q1 2026, an estimated $379K.
- GSK made up 0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #963 holding.
- Integrated Wealth Concepts first reported a position in GSK in Q4 2017 and has held it in 32 quarters since.
- Integrated Wealth Concepts's GSK position peaked at $1.55M in Q3 2020.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.